Guardant Health, Inc. Share Price

Guardant Health, Inc. Share Price

NASDAQ: GH | Large Cap
$185.35
+$2.93 (1.61%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Guardant Health, Inc. Stock Performance

Open
$183.44
Prev. Close
$182.42
Circuit Range
N/A
Day Range
$182.76 - $185.85
Year Range
$68.39 - $190.69
Volume
68,820
Average Traded
$184.90

Guardant Health, Inc. Share Price Today

As of 30 October 2026, Guardant Health, Inc.'s share price is $185.35. The stock opened at $183.44, compared to its previous close of $182.42. During today's trading session, Guardant Health, Inc.'s share price traded between $182.76 and $185.85, with an average price of $184.31. Over the past 52 weeks, the stock has recorded a high of $190.69 and a low of $68.39. In terms of performance, Guardant Health, Inc.'s share price has risen by 112.61% over the last six months and is up 99.25% on a year-on-year basis.

Guardant Health, Inc. Share Price Chart

Line chart of the Guardant Health, Inc. price trend over the selected period. The price rose overall, ranging from 182.01 to 185.96, ending at 185.35.
$182.76$185.85
L
Show Current Price
H

Guardant Health, Inc. Stock Fundamentals & Key Indicators

Market Cap
$23.24B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.38
Revenue (TTM)
$982.02B
Return On Equity (TTM)
203.46%
Profit Margin
-42.39%
Debt to Equity
-6.74
Quarterly Earnings Growth YoY
-29.56%

Guardant Health, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$265.20$281.27$301.67$334.98
Net Profit-$92.73-$128.49-$112.08-$120.14
Net Profit Margin-34.97%-45.68%-37.15%-35.86%
Income ChangeN/A-38.56%12.77%-7.19%

Guardant Health, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$449.54$563.95$739.02$982.02
Net Profit-$654.59-$479.45-$436.37-$416.28
Net Profit Margin-145.61%-85.02%-59.05%-42.39%
Income ChangeN/A26.76%8.99%4.60%

About Guardant Health, Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$177.75
$185.34
+3.80%
Sep 2026
$157.99
$178.56
+6.02%
Aug 2026
$158.46
$168.41
+4.04%
Jul 2026
$159.69
$161.87
+7.81%
Jun 2026
$127.59
$150.14
+15.72%
May 2026
$87.91
$129.74
+48.82%
Apr 2026
$94.81
$87.18
-5.65%
Mar 2026
$92.89
$92.41
-1.65%
Feb 2026
$113.23
$93.96
-17.65%
Jan 2026
$101.98
$114.10
+11.74%
Dec 2025
$106.41
$102.11
-5.79%
Nov 2025
$93.72
$108.39
+16.52%

GH Share Price FAQs